Navigation Links
Emerging Markets for Enzyme Inhibitors Surge, To Grow More Than 50% by 2016
Date:6/25/2012

FARMINGTON, Conn., June 25, 2012 /PRNewswire-iReach/ -- The enzyme inhibitors industry in emerging markets has significant potential, in contrast to mature markets where growth is significantly slower. Having accurate market data and analysis is essential to companies that wish to compete on the global stage. With premium market research from the world's leading publishers, Global Information Inc. helps businesses stay on the cutting edge with the best forecasts, research, and analyses.

(Photo: http://photos.prnewswire.com/prnh/20120625/CG29914)

Global Information is pleased to announce the immediate availability of three significant new reports on Enzyme Inhibitors.

Global Markets for Enzyme Inhibitors -- Focus on Europe

Global Markets for Enzyme Inhibitors -- Focus on US

Global Markets for Enzyme Inhibitors -- Focus on Emerging Markets

The overall goal of this series is to provide a comprehensive understanding of the current and future characteristics for enzyme inhibitors, which include proton pump inhibitors (PPIs), protease inhibitors, reverse transcriptase inhibitors, kinase inhibitors, statins, aromatase inhibitors, phosphodiesterase type 5 (PDE5) inhibitors, neuraminidase inhibitors, and angiotensin-converting enzyme (ACE) inhibitors.

Each report offers Market sizes with 5-year forecasts from 2011 to 2016 for enzyme inhibitors in the pharmaceutical and biotechnology industry. These include market projections and market shares as well as a technology SWOT analysis.

Due to patent expiry, the US Enzyme Inhibitors market declined in 2011, down to $44.9 billion from $46.8 billion in 2010. The US market is expected to recover slowly to $47.4 billion by 2016, at a CAGR of 1.1%. The US kinase inhibitors market fell to $10.4 billion in 2011 from $10.8 billion in 2010. This market is expected to recover to $11.6 billion by 2016, a CAGR of 2.2%.

European Markets held mostly flat in 2011. The European market for enzyme inhibitors was $32 billion in 2010 and rose to $32.4 billion in 2011, and will rise at a CAGR of 3.6% to reach nearly $38.7 billion by 2016. European sales of kinase inhibitors were also mostly flat, at $9.2 billion in 2010 and $9.4 billion in 2011, but are forecast to reach $11.6 billion by 2016 at a CAGR of 4.4%.

The greatest potential by far lies in the emerging markets of India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.  Enzyme inhibitors in these markets are estimated at $25.6 billion in 2010 and $27.2 billion in 2011, expected to rise at a CAGR of 8.7% and reach nearly $41.3 billion through 2016. Kinase inhibitors in particular were $8.2 billion in 2010 and $9.3 billion in 2011, set to grow at a CAGR of 13% to reach nearly $17.1 billion by 2016.

An Executive Summary of this analysis and a free sample of each report is available from Global Information, Inc:

Emerging Markets
http://www.giiresearch.com/report/bc245534-global-markets-enzyme-inhibitors-focus-on-emerging.html

US Markets
http://www.giiresearch.com/report/bc245535-global-markets-enzyme-inhibitors-focus-on-us.html

European Markets
http://www.giiresearch.com/report/bc245533-global-markets-enzyme-inhibitors-focus-on-europe.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Increasing Incidence of Cardiovascular Diseases to Drive The Cardiovascular Devices Market in Emerging Countries
2. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
3. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
4. LTCLINK-Tank Competition Announced To Introduce Your Emerging Product to the Aging Care Continuum
5. Emerging Trends in Medical Device Outsourcing and Contract Manufacturing
6. Post-Recession, the Global Market for Surgical Equipment Picks Up Speed, Particularly In China and Emerging Economies
7. MD+DI, MPMN, Qmed and CMDM Announce Emerging Trends in Medical Device
8. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
9. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
10. Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
11. MarketsandMarkets: Global Endoscopy Market worth $9.7 Billion by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ... Aspen Surgical facility in Las Piedras, Puerto ... scalpels and blades. ... that the facility sustained minor structural damage, temporary loss ... Maria. Repairs have been completed, manufacturing operations have resumed, ...
(Date:10/10/2017)... 10, 2017   West Pharmaceutical Services, Inc. ... injectable drug administration, today shared the results of a ... improving the intradermal administration of polio vaccines. The study ... in May 2017 by Dr. Ondrej Mach , ... Health Organization (WHO), and recently published in the journal ...
(Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
Breaking Medicine News(10 mins):